anxiety disorder

BNC210 (IW-2143) is a α7 nAChR negative allosteric modulator. BNC210 has potent activity in animal models of anxiety and depression.

Troriluzole is an orally active glutamate modulator with anticancer activity.Troriluzole enhances the expression of excitatory amino acid transporters located in glial cells and is used in the study of spinocerebellar ataxia, Alzheimer's disease, and generalized anxiety disorder (GAD).

Troriluzole hydrochloride is the third-generation tripeptide precursor of Riluzole and acts as an orally active glutamate modulator. It reduces synaptic glutamate levels while enhancing glutamate uptake. Troriluzole hydrochloride has potential applications for treating Alzheimer's disease and generalized anxiety disorder (GAD).